These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 22748085

  • 1. Evaluation of the effectiveness of manual chest physiotherapy techniques on quality of life at six months post exacerbation of COPD (MATREX): a randomised controlled equivalence trial.
    Cross JL, Elender F, Barton G, Clark A, Shepstone L, Blyth A, Bachmann MO, Harvey I.
    BMC Pulm Med; 2012 Jul 02; 12():33. PubMed ID: 22748085
    [Abstract] [Full Text] [Related]

  • 2. A randomised controlled equivalence trial to determine the effectiveness and cost-utility of manual chest physiotherapy techniques in the management of exacerbations of chronic obstructive pulmonary disease (MATREX).
    Cross J, Elender F, Barton G, Clark A, Shepstone L, Blyth A, Bachmann M, Harvey I, MATREX Research Group.
    Health Technol Assess; 2010 May 02; 14(23):1-147, iii-iv. PubMed ID: 20487638
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.
    Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K.
    Health Technol Assess; 2015 May 02; 19(36):1-516. PubMed ID: 25980984
    [Abstract] [Full Text] [Related]

  • 6. Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial.
    Duenk RG, Verhagen C, Bronkhorst EM, van Mierlo P, Broeders M, Collard SM, Dekhuijzen P, Vissers K, Heijdra Y, Engels Y.
    Int J Chron Obstruct Pulmon Dis; 2017 May 02; 12():2795-2806. PubMed ID: 29033560
    [Abstract] [Full Text] [Related]

  • 7. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J, Francis NA, White P, Gillespie D, Thomas-Jones E, Breen R, Kirby N, Hood K, Gal M, Phillips R, Naik G, Cals J, Llor C, Melbye H, Wootton M, Riga E, Cochrane A, Howe R, Fitzsimmons D, Sewell B, Alam MF, Butler CC.
    Trials; 2017 Sep 29; 18(1):442. PubMed ID: 28969667
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care.
    Slok AH, Kotz D, van Breukelen G, Chavannes NH, Rutten-van Mölken MP, Kerstjens HA, van der Molen T, Asijee GM, Dekhuijzen PN, Holverda S, Salomé PL, Goossens LM, Twellaar M, In 't Veen JC, van Schayck OC.
    BMJ Open; 2016 Jul 11; 6(7):e011519. PubMed ID: 27401361
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Self-management for bronchiectasis.
    Kelly C, Grundy S, Lynes D, Evans DJ, Gudur S, Milan SJ, Spencer S.
    Cochrane Database Syst Rev; 2018 Feb 07; 2(2):CD012528. PubMed ID: 29411860
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life.
    Camac ER, Voelker H, Criner GJ, COPD Clinical Research Network and the Canadian Institutes of Health Research.
    Respir Med; 2021 Sep 07; 186():106526. PubMed ID: 34229290
    [Abstract] [Full Text] [Related]

  • 16. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease.
    Rutten-van Mölken MP, van Nooten FE, Lindemann M, Caeser M, Calverley PM.
    Pharmacoeconomics; 2007 Sep 07; 25(8):695-711. PubMed ID: 17640111
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.